Celia M Sharp

Title: Celia M. Sharp: Innovator in Biomedical Research

Introduction

Celia M. Sharp is a prominent inventor based in Doylestown, PA, known for her significant contributions to biomedical research. With a total of four patents to her name, she has made remarkable advancements in the field of human basic fibroblast growth factor (bFGF) and its applications in medicine.

Latest Patents

Celia's latest patents focus on methods of using analogs of human basic fibroblast growth factor mutated at specific positions. One of her notable inventions relates to novel muteins of bFGF with superagonist properties. This invention includes both the protein and the respective encoding nucleic acid species. Additionally, it encompasses vectors and host cells for the propagation of these nucleic acid sequences and the production of the muteins. The disclosed methods aim to stimulate cell division and provide treatments for various medical conditions, including wound healing, ischemia, heart disease, neural injury, peripheral vascular disease, gastric ulcers, and duodenal ulcers.

Career Highlights

Celia M. Sharp has established herself as a key figure in her field through her innovative research and patent contributions. Her work has the potential to impact various therapeutic areas, showcasing her dedication to advancing medical science.

Collaborations

Celia has collaborated with notable colleagues, including Barry A. Springer and Michael W. Pantoliano, further enhancing her research endeavors and contributions to the scientific community.

Conclusion

Celia M. Sharp's innovative work in the field of biomedical research exemplifies her commitment to improving healthcare through scientific advancements. Her patents reflect her expertise and the potential for significant medical breakthroughs.